Inventor
WEMPE MICHAEL FITZPATRICK
US10 patents
⚠️ This page may combine multiple inventors who share the name “WEMPE MICHAEL FITZPATRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV COLORADO REGENTS
8 patentsUS9353121B2May 31, 2016
Anti-cancer compounds targeting Ral GTPases and methods of using the same
UNIV COLORADO REGENTS7 citations82
US10676480B2Jun 9, 2020
Anti-cancer compounds targeting Ral GTPases and methods of using the same
UNIV COLORADO REGENTS2 citations71
US10202397B2Feb 12, 2019
Anti-cancer compounds targeting Ral GTPases and methods of using the same
UNIV COLORADO REGENTS2 citations71
US11964985B2Apr 23, 2024
Anti-cancer compounds targeting Ral GTPases and methods of using the same
UNIV COLORADO REGENTS0 citations60
US11472812B2Oct 18, 2022
Anti-cancer compounds targeting Ral GTPases and methods of using the same
UNIV COLORADO REGENTS0 citations60
USRE48557EMay 18, 2021
Anti-cancer compounds targeting Ral GTPases and methods of using the same
UNIV COLORADO REGENTS0 citations60
US10689392B2Jun 23, 2020
Anti-cancer compounds targeting ral GTPases and methods of using the same
UNIV COLORADO REGENTS0 citations50
US12043601B2Jul 23, 2024
N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same
UNIV COLORADO REGENTS0 citations48
WEMPE MICHAEL FITZPATRICK
2 patentsUS8263094B2Sep 11, 2012
Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
WEMPE MICHAEL FITZPATRICK2 citations57
US8183398B2May 22, 2012
5-hydroxy-2-methyl-4H-pyran-4-one esters as novel tyrosinase inhibitors
WEMPE MICHAEL FITZPATRICK0 citations43